Amgen Inc. (AMGN) Fundamentals

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
SHARE INFORMATION
Market Cap$ 131,647,020,000
Shares Outstanding534,000,000
Float533,424,304
Percent Float99.89%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 7.76
Latest Fiscal Revenue$ 26,323,000,000
Latest Fiscal EPS$ 12.11
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 10.17
Dividend (5 Years)$ 10.76
Ex Dividend Date2023-02-14
Dividend Rate$ 8.52
Dividend Yield3.46%
Payment CashCash
HOLDERS
Institutions3,775
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months17,797,678
Institutional Holdings Percent139.6%
Institutional Sold Previous 3 Months39,277,011
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months615
Insider Holdings Percent0.6
Insider Sold Previous 3 Months8,687
Insider Shares Owned3,221,417
TRADING INFO
52 Week High$ 296.67
52 Week Low$ 214.39
52 Week High Change$ 11.09
21 Day Moving Average$ 262.2741
21 Day Extended Moving Average$ 259.1954
50 Day Moving Average$ 269.6523
50 Day Extended Moving Average$ 263.9495
200 Day Moving Average$ 250.8892
200 Day Extended Moving Average$ 254.5409
10 Day Average Volume2,897,348
20 Day Average Volume2,491,918
30 Day Average Volume2,244,721
50 Day Average Volume2,626,480
Alpha0.005035
Beta0.6297
Standard Deviation0.070011
R20.235985
7 Day Price Change$ -8.35
7 Day Percent Change-3.28%
21 Day Price Change$ -24.39
21 Day Percent Change-9.0%
30 Day Price Change$ -16.11
30 Day Percent Change-6.13%
Month to Date Price Change$ -5.87
Month to Date Percent Change-2.33%
Quarter to Date Price Change$ -16.11
Quarter to Date Percent Change-6.13%
180 Day Price Change$ 6.14
180 Day Percent Change2.56%
200 Day Price Change$ 1.43
200 Day Percent Change0.59%
Year to Date Price Change$ -16.11
Year to Date Percent Change-6.13%

Amgen Inc. (AMGN) Key Ratios

PROFITABILITY
EBIT Margin34.4%
EBITDA Margin47.1%
Pre-Tax Profit Margin33.3%
Profit Margin Count24.89%
Gross Margin74.2%
Profit Margin TOT24.89%
INCOME STATEMENTS
Revenue$ 26,323,000,000
Revenue Per Share$ 49.294
Revenue (3 Years)$ 3.87
Revenue (5 Years)$ 3.08
FINANCIAL STRENGTH
Price to Tangible Book-4.70
Total Debt To Equity10.60
Int Coverage6.20
Current Ratio1.40
Leverage Ratio23.20
Quick Ratio0.40
Long Term Debt To Capital0.91
VALUATION MEASURES
PE Ratio20.30
Enterprise Value$ 161,222,940,000
Price to Sales5.0012
Price to Free Cash22.00
PE High Last 5 Years78.10
Price To Book35.90
Price To Cash Flow13.70
PE Low Last 5 Years13.20
Price to Tangible Book-4.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.20
Invoice Turnover1.40
Assets Turnover0.20
Return Assets10.38
Return on Equity126.47
Return on Capital18.17

Amgen Inc. (AMGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORobert A. Bradway
Emplyoees24200
Last AuditUQ
CIK0000318154
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressOne Amgen Center Drive
Thousand Oaks, CA 91320-1799
Websitehttps://www.amgen.com
Facsimile+1 805 447-1010
Telephone+1 805 447-1000
Emailinvestor.relations@amgen.com
Your Recent History
NASDAQ
AMGN
Amgen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230204 09:47:35